Sablon-Regence SRL

Sablon-Regence reported total assets of €1.54m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).

Company number (CBE) 0425.508.316 · VAT BE0425508316
1050 Brussels
active in Manufacture of wire products, chain and springs (NACE 2593003)
operating since 20 Mar 1984 (≈ 42 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Sablon-Regence shows with a free account.

See the score
Profile
SRL since 1984
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−90,032 €
Equity136,635 €
Cash2,528 €
EBITDA−10,154 €
Total assets€1.54m
The line marks its sector median: 54.1% (20 companies).

Change 2022 → 2025: Equity -53 % Total assets -31 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Sablon-Regence's annual accounts

20252024202320222021
Net result−90,032 €
Equity136,635 €
Cash2,528 €
EBITDA−10,154 €
Total assets€1.54m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Jul 2026
  • Year ended 31 Dec 2024filed on 30 Jul 2025
  • Year ended 31 Dec 2023filed on 18 Aug 2024
  • Year ended 31 Dec 2022filed on 27 Oct 2023
  • Year ended 31 Dec 2021filed on 28 Jul 2022

Sablon-Regence's financial analysis

Management and control of Sablon-Regence

1 active director(s) in the register.

Sablon-Regence's shareholders and holdings →

Sablon-Regence's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0425.508.316
VAT number
BE0425508316
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
20 Mar 1984
Registered office
1050 Brussels
Latest accounts
2025 · filed on 31 Jul 2026
Activity
Manufacture of wire products, chain and springs (NACE 2593003)

Sablon-Regence (SRL) has been based in Brussels since 1984, active in: manufacture of wire products, chain and springs. For 2025, it reports a net loss of 90,032 € and equity of 136,635 €; its revenue is not published. Its solvency stands at 8.9%, below the median of its sector (54.1%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Sablon-Regence

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Sablon-Regence

What is the revenue of Sablon-Regence?

Sablon-Regence files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Sablon-Regence?

In Belgium, the VAT number is the company number prefixed with BE: BE0425508316 for Sablon-Regence, if the company is VAT-registered. Its company number (CBE) is 0425.508.316.

Where is the registered office of Sablon-Regence?

According to the CBE register, the registered office of Sablon-Regence is in 1050 Brussels.

What is the equity of Sablon-Regence?

At the close of the 2025 financial year, the equity of Sablon-Regence amounts to 136,635 €, a solvency of 8.9% of total assets.

Who manages Sablon-Regence?

The register lists 1 active mandates at Sablon-Regence. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Sablon-Regence

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 02 Aug 2026

No credit card, no commitment.

What each plan unlocks →